• Tiffaney Tran, Peggy R Cyr, Alex Verdieck, Miranda D Lu, Hadjh T Ahrns, Elizabeth G Berry, William Bowen, Ralph P Braun, Joshua M Cusick-Lewis, Hung Q Doan, Valerie L Donohue, Deborah R Erlich, Laura K Ferris, Evelyne Harkemanne, Rebecca I Hartman, James Holt, Natalia Jaimes, Timothy A Joslin, Zhyldyz Kabaeva, Tracey N Liebman, Joanna Ludzik, Ashfaq A Marghoob, Isac Simpson, Jennifer A Stein, Daniel L Stulberg, Isabelle Tromme, Matthew J Turnquist, Richard P Usatine, Alison M Walker, Bryan L Walker, Robert F West, Megan L Wilson, Alexander Witkowski, Dominic J Wu, Elizabeth V Seiverling, and Kelly C Nelson.
• From the Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston (TT, HQD, KCN); Department of Family Medicine, Maine Medical Center, Portland (PRC, HTA); Department of Family Medicine, Tufts University School of Medicine, Boston, MA (PRC, DRE); Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland (AV, TAJ); Swedish First Hill Family Medicine Residency, Seattle, WA (MDL); Department of Dermatology, Oregon Health & Science University School of Medicine, Portland (EGB, JL, AW); Christus St. Vincent Family Medicine Center, Sante Fe, NM (WB); Department of Dermatology, University Hospital of Zürich, University of Zürich, Zürich, Switzerland (RPB); Cabin Creek Health Systems, Dawes, WV (JMC-L); Lincoln Medical Partners, Damariscotta, ME (VLD); Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA (LKF); Dermatology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium (EH); Institute of Experimental & Clinical Research, Université Catholique de Louvain, Brussels, Belgium (EH); Department of Dermatology, Brigham and Women's Hospital, Boston, MA (RIH); Melanoma Program, Dana-Farber Cancer Institute, Boston, MA (RIH); Veterans Integrated Services Network, Jamaica Plain, MA (RIH); Department of Family Medicine, East Tennessee State University James H. Quillen College of Medicine, Johnson City, TN (JH); Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL (NJ); Sylvester Comprehensive Cancer Center, Miami, FL (NJ); Department of Internal Medicine, Maine Medical Center, Cape Elizabeth, ME (ZK); The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York (TNL, JAS); Department of Telemedicine and Bioinformatics, Jagiellonian University Medical College, Krakow, Poland (JL); Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY (AAM); Simpson DermCare & Family Medicine, Ammon, ID (IS); Department of Family & Community Medicine, University of New Mexico School of Medicine, Albuquerque (DLS); Dermatology Department, King Albert II Cancer and Hematology Institute, Cliniques Universitaires Saint-Luc, Brussels, Belgium (IT); Department of Family Medicine, Millinocket Regional Hospital, Millinocket, ME (MJT); Western Maine Primary Care, Norway (MJT); Department of Dermatology & Cutaneous Surgery, Department of Family & Community Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU); Brigham and Women's Health Care Center, Pembroke, MA (AMW); South Shore Medical Center, Norwell, MA (BLW); Redirect Health, Glendale, AZ (RFW); Department of Family Medicine, University of Washington School of Medicine, Seattle (MLW); Department of Dermatology, University of Kansas Medical Center, Kansas City (DJW); Division of Dermatology, Maine Medical Center, Portland (EVS); Department of Dermatology, Tufts University School of Medicine, Boston, MA (EVS).
• J Am Board Fam Med. 2023 Feb 8; 36 (1): 253825-38.

BackgroundPrimary care providers (PCPs) frequently address dermatologic concerns and perform skin examinations during clinical encounters. For PCPs who evaluate concerning skin lesions, dermoscopy (a noninvasive skin visualization technique) has been shown to increase the sensitivity for skin cancer diagnosis compared with unassisted clinical examinations. Because no formal consensus existed on the fundamental knowledge and skills that PCPs should have with respect to dermoscopy for skin cancer detection, the objective of this study was to develop an expert consensus statement on proficiency standards for PCPs learning or using dermoscopy.MethodsA 2-phase modified Delphi method was used to develop 2 proficiency standards. In the study's first phase, a focus group of PCPs and dermatologists generated a list of dermoscopic diagnoses and associated features. In the second phase, a larger panel evaluated the proposed list and determined whether each diagnosis was reflective of a foundational or intermediate proficiency or neither.ResultsOf the 35 initial panelists, 5 PCPs were lost to follow-up or withdrew; 30 completed the fifth and last round. The final consensus-based list contained 39 dermoscopic diagnoses and associated features.ConclusionsThis consensus statement will inform the development of PCP-targeted dermoscopy training initiatives designed to support early cancer detection.© Copyright by the American Board of Family Medicine.

19 keywords...

hide…